GenSight Biologics
SIGHT.PA
#9645
Rank
A$59.84 M
Marketcap
$0.46
Share price
-4.78%
Change (1 day)
-31.74%
Change (1 year)

Revenue for GenSight Biologics (SIGHT.PA)

Revenue in 2024: A$2.43 Million

According to GenSight Biologics's latest financial reports the company's current revenue (TTM ) is A$2.43 Million. In 2024 the company made a revenue of A$2.43 Million an increase over the revenue in the year 2023 that were of A$2.18 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GenSight Biologics from 2013 to 2024

Annual revenue

Year Revenue Change
2024A$2.43 M11.45%
2023A$2.18 M-49.43%
2022A$4.32 M-53.65%
2021A$9.32 M10.56%
2020A$8.43 M589.22%
2019A$1.22 M
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A